Download presentation
Presentation is loading. Please wait.
Published byかずし いくのや Modified over 5 years ago
1
Preoperative Beta-Blocker Usage: Is It Really Worthy of Being a Quality Indicator?
William T. Brinkman, MD, Morley A. Herbert, PhD, Syma L. Prince, RN, BSN, Mitchell J. Magee, MD, Todd M. Dewey, MD, Robert L. Smith, MD, James R. Edgerton, MD, Stuart J. Head, BS, William H. Ryan, MD, Michael J. Mack, MD The Annals of Thoracic Surgery Volume 92, Issue 3, Pages (September 2011) DOI: /j.athoracsur Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions
2
Fig 1 Change in observed to expected ratio for operative mortality with increasing use of β- blockers in the unmatched and matched patient groups. The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions
3
Fig 2 Relative risk/benefit for predefined subgroups of matched patient group. (LV = left ventricular.) The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.